The independent medical news service
09-03-2021 | Oncology | News | Article
RCC obesity paradox holds true in ICI era
Researchers report an association between high BMI and improved outcomes in response to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.
17-06-2020 | Oncology | News | Article
Immunotherapy de-escalation in advanced RCC not feasible yet
Results from two studies presented at the virtual 2020 ASCO Annual Meeting suggest that the strategy of using single-agent nivolumab followed by response-adaptive or salvage add-on ipilimumab cannot be recommended for patients with advanced renal cell carcinoma.
This independent news story was supported by an educational grant from Pfizer and Merck KGa
Doctor and patient/© fizkes / Getty Images / iStock (Symbolic Image with Models), Human kidney cross section/© hywards / stock.adobe.com, Pills_various/© nikesidoroff / fotolia.com, Fausto Castagnetti, Man receiving radiotherapy/© Mediteraneo / Fotolia, Pills in hand/© stock_colors / Getty Images / iStock, Male & female outlines_chalk/© TimArbaev / iStock / Thinkstock, Hisham Mehanna/© Lynda Williams, Barbara Burtness, Elizabeth Phillips, Nilanjan Ghosh, Matthew Wilson, Charles Herbaux, Pipette_rack with samples/© science photo / Fotoli, Thomas John